Andlauer Healthcare Group (TSE:AND – Get Free Report) had its target price reduced by stock analysts at TD Securities from C$54.00 to C$53.00 in a research note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target points to a potential upside of 31.42% from the stock’s current price.
Several other equities analysts have also recently commented on the company. National Bankshares upped their price target on Andlauer Healthcare Group from C$45.00 to C$49.00 and gave the company a “sector perform” rating in a report on Tuesday, February 11th. Stifel Nicolaus upped their price target on Andlauer Healthcare Group from C$50.00 to C$52.00 in a report on Monday, February 24th. Finally, Scotiabank upped their price target on Andlauer Healthcare Group from C$43.00 to C$44.00 in a report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, Andlauer Healthcare Group currently has an average rating of “Moderate Buy” and a consensus price target of C$48.71.
Check Out Our Latest Stock Analysis on AND
Andlauer Healthcare Group Trading Down 4.5 %
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
See Also
- Five stocks we like better than Andlauer Healthcare Group
- What is a penny stock? A comprehensive guide
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- How to Invest in Biotech Stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What is the S&P/TSX Index?
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.